Sun, Xiaodong

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Hay, S. I., Ong, K. L., Santomauro, D. F., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abaraogu, U. O., Abate, B. B., Abbafati, C., et al. (2025) · The Lancet

Global Health and EpidemiologyCardiovascular Health and Risk Factors

Cited by 916

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Naghavi, M., Kyu, H. H., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abafita, B. J., Abaraogu, U. O., Abbafati, C., Abbasi, M., et al. (2025) · The Lancet

Insurance, Mortality, Demography, Risk ManagementGlobal Health and Epidemiology

Cited by 595

Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating Sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet-induced obese mice

Sun, X., Han, F., Lu, Q., Li, X., Ren, D., Zhang, J., Han, Y., Xiang, Y. K., & Li, J. (2020) · Diabetes

Cardiovascular Function and Risk FactorsDiabetes Treatment and Management

Cited by 193

AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

Lu, Q., Li, X., Liu, J., Sun, X., Rousselle, T., Ren, D., Tong, N., & Li, J. (2019) · Bioscience Reports

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 69

Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway

Han, X., Ding, C., Zhang, G., Pan, R., Liu, Y., Huang, N., Hou, N., Han, F., Xu, W., & Sun, X. (2020) · Biochemical and Biophysical Research Communications

Liver Disease Diagnosis and TreatmentGenomics, phytochemicals, and oxidative stress

Cited by 63

Secreted frizzled-related proteins: A promising therapeutic target for cancer therapy through Wnt signaling inhibition

Zhang, W., Zhang, K., Ma, Y., Song, Y., Qi, T., Xiong, G., Zhang, Y., Kan, C., Zhang, J., Han, F., et al. (2023) · Biomedicine & Pharmacotherapy

Wnt/β-catenin signaling in development and cancerHedgehog Signaling Pathway Studies

Cited by 22